Simon Laban

University Cancer Center Hamburg, University Hospital Ulm, University Medical Center Hamburg-Eppendorf

Papers

Total Citations

H-Index

About

Simon Laban is a leading surgical oncologist whose research centers on the treatment of head and neck cancer, with a particular focus on HPV-positive oropharyngeal squamous cell carcinoma (OPSCC). His work has been instrumental in advancing transoral robotic surgery (TORS) and refining multimodal treatment strategies. Laban’s most cited paper, “New treatment strategies for HPV-positive head and neck cancer” (2013, 67 citations), critically evaluated the evolving landscape of de-escalation protocols and surgical innovations for this biologically distinct tumor type, helping to shape clinical paradigms. He is also the principal investigator of the TopROC trial (2020, 13 citations), a landmark comparative effectiveness study that directly compares transoral surgery with adjuvant therapy versus primary radiochemotherapy for resectable OPSCC—addressing a long-standing equipoise in the field. Additionally, his work on the development of TORS in Europe (2013, 10 citations) documents the early adoption and technical standardization of this minimally invasive approach across the continent. With a career dedicated to improving oncologic outcomes while preserving function, Laban’s research has garnered over 90 citations and continues to influence evidence-based surgical decision-making in head and neck oncology.